ÂÜÀòÂÒÂ×

Dean has over 15 years of commercial and research experience in biotechnology, pharmaceuticals, and medical devices. He has worked extensively with senior management teams at companies in Europe, North America, and Asia to build successful corporate, commercial, and R&D strategies and capabilities.

Dean has broad experience supporting companies develop asset, portfolio, and corporate strategies, ranging from therapeutic area growth strategy to gene therapy platform development and transactional support. In addition, he brings extensive experience across the global commercial landscape for therapeutics, diagnostics, and digital technologies.

Prior to joining ClearView, Dean worked in life sciences consulting for over 10 years following academic research in stem cell biology, epigenetics, transcriptional regulation, and cancer.

Dean received his Ph.D. in Stem Cell Biology from the University of Edinburgh and a BSc (Hons) in Molecular Genetics from King’s College London.